
Aksel Lund Svindal
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- U.S. and China finalize TikTok transfer deal, part of broader agreement
- Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- U.S. and China finalize TikTok transfer deal, part of broader agreement
- Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Aksel Lund Svindal
News from Aksel Lund Svindal
